351 related articles for article (PubMed ID: 31668396)
1. PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease.
Rana R; Shearer AM; Fletcher EK; Nguyen N; Guha S; Cox DH; Abdelmalek M; Wang Y; Baleja JD; Covic L; Kuliopulos A
Mol Metab; 2019 Nov; 29():99-113. PubMed ID: 31668396
[TBL] [Abstract][Full Text] [Related]
2. PAR2 promotes high-fat diet-induced hepatic steatosis by inhibiting AMPK-mediated autophagy.
Kim BM; Kim DH; Park YJ; Ha S; Choi YJ; Yu HS; Chung KW; Chung HY
J Nutr Biochem; 2021 Sep; 95():108769. PubMed ID: 34000413
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
Kumar S; Verma AK; Rani R; Sharma A; Wang J; Shah SA; Behari J; Salazar Gonzalez R; Kohli R; Gandhi CR
Hepatology; 2020 Nov; 72(5):1586-1604. PubMed ID: 32031683
[TBL] [Abstract][Full Text] [Related]
4. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
Jeong MJ; Kim SR; Jung UJ
Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
[TBL] [Abstract][Full Text] [Related]
5. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
6. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
7. Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet.
Chun HJ; Shim YJ; Kwon YH
J Nutr Biochem; 2022 Feb; 100():108869. PubMed ID: 34563665
[TBL] [Abstract][Full Text] [Related]
8. Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin.
Shearer AM; Rana R; Austin K; Baleja JD; Nguyen N; Bohm A; Covic L; Kuliopulos A
J Biol Chem; 2016 Oct; 291(44):23188-23198. PubMed ID: 27613872
[TBL] [Abstract][Full Text] [Related]
9. Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease.
Toita R; Kang JH
Toxicol Lett; 2020 Oct; 332():1-6. PubMed ID: 32579995
[TBL] [Abstract][Full Text] [Related]
10. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
[TBL] [Abstract][Full Text] [Related]
11. PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference.
Shearer AM; Wang Y; Fletcher EK; Rana R; Michael ES; Nguyen N; Abdelmalek MF; Covic L; Kuliopulos A
Hepatology; 2022 Dec; 76(6):1778-1793. PubMed ID: 35603482
[TBL] [Abstract][Full Text] [Related]
12. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
[TBL] [Abstract][Full Text] [Related]
13. Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model.
Ipsen DH; Skat-Rørdam J; Tsamouri MM; Latta M; Lykkesfeldt J; Tveden-Nyborg P
Mol Genet Genomics; 2019 Jun; 294(3):649-661. PubMed ID: 30759275
[TBL] [Abstract][Full Text] [Related]
14. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
[TBL] [Abstract][Full Text] [Related]
15. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease.
Li X; Wang Z; Klaunig JE
Toxicology; 2018 Dec; 410():199-213. PubMed ID: 30120929
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
Min-DeBartolo J; Schlerman F; Akare S; Wang J; McMahon J; Zhan Y; Syed J; He W; Zhang B; Martinez RV
PLoS One; 2019; 14(12):e0226854. PubMed ID: 31891606
[TBL] [Abstract][Full Text] [Related]
17. Heterozygous midnolin knockout attenuates severity of nonalcoholic fatty liver disease in mice fed a Western-style diet high in fat, cholesterol, and fructose.
Kweon SM; Irimia-Dominguez J; Kim G; Fueger PT; Asahina K; Lai KK; Allende DS; Lai QR; Lou CH; Tsark WM; Yang JD; Ng DS; Lee JS; Tso P; Huang W; Lai KKY
Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G147-G157. PubMed ID: 37129245
[TBL] [Abstract][Full Text] [Related]
18. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
20. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]